短期研修していただいた先生の業績

国際学会発表

第60回米国血液学会 (ASH2018)
吉藤康太先生
Clinical Efficacy of Prebiotics on Transplantation-Related Complications

国際誌

Mukae J, Sadato D, Toya T, et al. Labile CD22 and CD19 expression in a case of Philadelphia chromosome-like acute lymphoblastic leukemia. Leuk Lymphoma. 2022 Dec;63(13):3261-3264.

Shirane S, Najima Y, Fukushima K, et al. Central nervous system mucormycosis in a patient with hematological malignancy: A case report and review of the literature. J Infect Chemother. 2022 Dec;28(12):1658-1662.

Akiyama M, Inamoto K, Katayanagi N, et al. Clinical features of thyroid dysfunction in adult patients after allogeneic hematopoietic stem cell transplantation. Rinsho Ketsueki. 2022;63(8):876-879.

Mukae J, Sekiya N, Kato C, et al. Haploidentical hematopoietic stem cell transplantation for graft failure in myelodysplastic syndrome/myeloproliferative neoplasm-unclassifiable complicated with Stenotrophomonas maltophilia bacteremia. Rinsho Ketsueki. 2022;63(8):849-854.

Tanabe K, Najima Y, Inokuchi T, et al. Klinefelter's syndrome diagnosed after inv(16) acute myeloid leukemia following germ cell tumor. Rinsho Ketsueki. 2022;63(7):746-752. (ジュニアレジデント)

Marumo A, Omori I, Tara S, et al. Cyclophosphamide-induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg/kg or less. Asia Pac J Clin Oncol. 2022 Mar 14;e13674.

Shirane S, Watanabe D, Sekiya N, et al. Paraplegia via hematogenous dissemination of Cunninghamella elegans (mucormycosis) after hematopoietic stem cell transplantation. Int J Infect Dis. 2021 Dec;113:210-212.

Yoshifuji K, Toya T, Yanagawa N, et al. CT classification of acute myeloid leukemia with pulmonary infiltration. Jpn J Radiol. 2021 Nov;39(11):1049-1058.

Yasuda S, Najima Y, Konishi T, et al. Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study. Leuk Res. 2021 Sep;108:106627.

Kumagai T, Doki N, Kobayashi T, et al. Vacuolar myelopathy after allogeneic bone marrow transplantation in a patient with acute lymphoblastic leukemia. Rinsho Ketsueki. 2020;61(11):1625-1627.

Yoshifuji K, Inamoto K, Kiridoshi Y, et al. Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation. Blood Adv. 2020 Oct 13;4(19):4607-4617.

Uchida T, Doki N, Kishida Y, et al. Tyrosine kinase inhibitor maintenance therapy following allogenic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Rinsho Ketsueki. 2020;61(1):11-19.

Yoshifuji K, Toya T, Adachi H, et al. Successful hematopoietic stem‑cell mobilization with plerixafor plus granulocyte‑colony stimulating factor in multiple myeloma patients treated with pomalidomide. Int J Hematol. 2019 Jul;110(1):115-118.

Yasuda S, Najima Y, Konishi T, et al. Disseminated adenovirus infection in a patient with relapsed refractory multiple myeloma undergoing autologous stem cell transplantation and pomalidomide/dexamethasone as salvage regimens. J Infect Chemother. 2019 May;25(5):371-375.

Ikeuchi K, Doki N, Takao A、et al. Extramedullary Gastric Relapse at the Time of Bone Marrow Relapse of Acute Lymphoblastic Leukemia after Allogeneic Bone Marrow Transplantation. Intern Med. 2017 Dec 1;56(23):3215-3217.

Senoo Y, Sekiya N, Sasaki S, et al. Diagnostic open brain biopsy following initial negative results of cerebrospinal fluid assessment for Toxoplasma. Transpl Infect Dis. 2017 Apr;19(2).

Hattori K, Doki N, Kurosawa S, et al. Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2017 Feb;96(2):319-321.

Murata Y, Kudo Y, Kakihana K, et al. Steroid Pulse Therapy for Blood Cell Recovery in Allogeneic Hematopoietic Stem Cell Transplantation. Intern Med. 2016;55(6):583-7.

Senoo Y, Yoshioka K, Kaito S, et al. Retrospective analysis of clinical outcomes of the patients with chronic myeloid leukemia who stopped administration of tyrosine kinase inhibitors: a single institution experience. Rinsho Ketsueki. 2016;57(12):2481-2489.

Narukawa K, Kakihana K, Fujiwara T, et al. Gastric Antral Vascular Ectasia during the Treatment of Chronic Myelogenous Leukemia with Imatinib Mesylate. Intern Med. 2016;55(1):69-72.

Ishida S, Doki N, Shingai N, et al. The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT). Ann Hematol. 2016 Jun;95(7):1145-50.

Ohta S, Najima Y, Imamura J Dasatinib-induced gastric antral vascular ectasia in a patient with acute lymphoblastic leukaemia. Br J Haematol. 2015 Jun;169(5):612.

Watanabe K, Doki N, Miura Y, et al. Toxic encephalopathy after exposure to azacitidine. Leuk Lymphoma. 2015 May;56(5):1538-9.

Umezawa Y, Kakihana K, Oshikawa G, et al. Clinical features and risk factors for developing varicella zoster virus dissemination following hematopoietic stem cell transplantation. Transpl Infect Dis. 2014 Apr;16(2):195-202